updated on 9 July 2025
Featured Event II YoungInnovation 17-18-19 September |
||||||||||||
Researchers have always played a fundamental role in finding solutions to complex challenges. For this reason, NanoInnovation is committed to encouraging and facilitating the participation of young researchers (under 35 years of age) in the scientific world and supporting their careers through mentoring activities. In line with these objectives, Young Innovation has evolved into a semi-independent event, now in its fourth edition, to be held from 17 to 19 September 2025, increasingly enriched with significant presences and aimed at the researchers of the future. Young Innovation has become a well-defined event consisting of three days of discussions, divided into 90-minute sessions. In particular, the sessions will be developed to include: 1. Parallel sessions focusing on the macro areas of Material Sciences and Life Sciences. 2. Other sessions covering topics common to both the above macro areas. Each Young Innovation session will include:
The specific topics of the event will be selected by the Chairs and the NanoInnovation Organizing Committee, who will also appoint the members of the Young Innovation Scientific Committee and the Organizing Committee. 1. the uploading of the abstract of their research through the website, on the dedicate submission section CALL FOR POSTERS. 2. the ticking the ‘Young Innovation” box during the submission. Selected abstract from the under-35 applicants, based on the quality of the proposed research and its relevance to the theme of the session, will be invited to presented during Young Innovation and could be displayed in printed form during Nanoinnovation and uploaded on the website in the dedicated session. |
||||||||||||
Chairs: SCIENTIFIC COMMITTEE PROGRAM COMMITTEE ORGANIZING BOARD |
||||||||||||
Co-organized with | ||||||||||||
![]() |
||||||||||||
17 September | ||||||||||||
09:00 - 10:30 Machine Learning Approach for advanced materials FE.II.1 - TT.I.H - FE.I.2 |
||||||||||||
Co-organized with | ||||||||||||
![]() |
||||||||||||
Chair: in definition | ||||||||||||
This session explores the use of machine learning in the development of advanced materials. As material discovery grows more complex, data-driven methods enable faster property prediction and design. Topics include supervised/unsupervised learning, neural networks, and AI tools for materials science. Both theoretical and experimental contributions are welcome, including case studies in energy, catalysis, polymers, ceramics, and alloys. | ||||||||||||
FE.II.1.1 TT.I.H.1 FE.I.2.1 |
in definition | ![]() |
||||||||||
FE.II.1.2 TT.I.H.2 FE.I.2.2 |
Leila SOHRABI-KASHANI School of Metallurgy and Materials Engineering, Iran University of Science and Technology,Tehran, Iran Effect of Additives on the Microscructure and structure of alumina nanofibers as catalyst support for methane combustion: a Machine Learning approach to Additive Selection |
![]() |
||||||||||
FE.II.1.3 TT.I.H.3 FE.I.2.3 |
in definition | ![]() |
||||||||||
FE.II.1.4 TT.I.H.4 FE.I.2.4 |
in definition | ![]() |
||||||||||
FE.II.1.5 TT.I.H.5 FE.I.2.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
09:00 - 10:30 Novel Therapeutic Frontiers for Brain Diseases: Emerging Strategies in Drug Delivery, Gene Therapy and Neuroregeneration FE.II.2 - TT.I.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Emanuela Fabiola CRAPARO, University of Palermo | ||||||||||||
FE.II.2.1 TT.I.I.1 |
Introductive Keynote Delia MANDRACCHIA University of Brescia Title in definition |
![]() |
||||||||||
FE.II.2.2 TT.I.I.2 |
in definition | ![]() |
||||||||||
FE.II.2.3 TT.I.I.3 |
in definition | ![]() |
||||||||||
FE.II.2.4 TT.I.I.4 |
in definition | ![]() |
||||||||||
FE.II.2.5 TT.I.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
11:30 - 13:00 2D materials FE.II.3 - TT.II.I - FE.I.3 |
||||||||||||
Co-organized with | ||||||||||||
![]() |
||||||||||||
Chair: in definition | ||||||||||||
FE.II.3.1 TT.II.I.1 FE.I.3.1 |
in definition | ![]() |
||||||||||
FE.II.3.2 TT.II.I.2 FE.I.3.2 |
in definition | ![]() |
||||||||||
FE.II.3.3 TT.II.I.3 FE.I.3.3 |
in definition | ![]() |
||||||||||
FE.II.3.4 TT.II.I.4 FE.I.3.4 |
in definition | ![]() |
||||||||||
FE.II.3.5 TT.II.I.5 FE.I.3.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
11:30 - 13:00 Translational Systems for Infectious Disease Management FE.II.4 - TT.II.J |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: in definition | ||||||||||||
This session explores the increasing importance of translational systems in biotechnology-based approaches to infectious disease control. As microbial resistance rises and novel pathogens emerge, bridging molecular research with clinical and public health applications has become a central challenge. By integrating systems biology, multi-omics data, and computational modeling, translational strategies are enabling more precise diagnostics, the development of next-generation therapeutics, and faster, more adaptive responses to outbreaks. The session focuses on scalable, interdisciplinary frameworks that support the efficient transition from bench to bedside. Case studies and recent advances will be analyzed to illustrate how translational biotechnology is reshaping infectious disease management. Particular attention is given to technologies and approaches that demonstrate real-world applicability, scientific rigor, and cross-sectoral collaboration. | ||||||||||||
FE.II.4.1 TT.II.J.1 |
Introductive Keynote Ivana D'ANGELO University of Campania “Luigi Vanvitelli” Nanocarriers for Antimicrobial Therapy: Innovations in Infectious Disease Treatment |
![]() |
||||||||||
FE.II.4.2 TT.II.J.2 |
in definition | ![]() |
||||||||||
FE.II.4.3 TT.II.J.3 |
in definition | ![]() |
||||||||||
FE.II.4.4 TT.II.J.4 |
in definition | ![]() |
||||||||||
FE.II.4.5 TT.II.J.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
14:00 - 15:30 Optical spectroscopy on low-dimensional materials FE.II.5 - TT.III.H |
||||||||||||
Co-organized with Sapienza University of Rome | ||||||||||||
Chair: in definition | ||||||||||||
This session explores recent advances in the optical spectroscopy of two-dimensional materials, including graphene, transition metal dichalcogenides (TMDs), 2D perovskites, and related systems. Presentations will cover techniques such as infrared, photoluminescence and Raman spectroscopy to investigate electronic structure, excitonic effects, and many-body interactions. Special focus will be given to the influence of dimensionality, strain, defects, and dielectric environment on optical properties. The session highlights both fundamental insights and emerging applications in photonics and quantum materials. Contributions from experimental and theoretical perspectives will foster interdisciplinary discussion and collaboration. | ||||||||||||
FE.II.5.1 TT.III.H.1 |
in definition | ![]() |
||||||||||
FE.II.5.2 TT.III.H.2 |
Erica FRAGOMENI - CV Sapienza University of Rome Modifications of electron-phonon coupling in K-doped bilayer graphene studied by means of infrared resonance Raman spectroscopy |
![]() |
||||||||||
FE.II.5.3 TT.III.H.3 |
Beatrice D'ALÒ - CV Sapienza University of Rome Inducing the exciton-to-trion conversion in monolayer WS2 under pressure |
![]() |
||||||||||
FE.II.5.4 TT.III.H.4 |
Fabrizio CIENZO - CV Sapienza University of Rome Quantum emitters in hexagonal boron nitride in ultra-high vacuum conditions |
![]() |
||||||||||
FE.II.5.5 TT.III.H.5 |
Pierpaolo BASSETTI - CV Sapienza University of Rome Strain induced room-temperature valley coherence in monolayer Transition Metal Dichalcogenides |
![]() |
||||||||||
Round table on the Topic | ||||||||||||
14:00 - 15:30 Bioinspired Platform for Genetic Material FE.II.6 - TT.III.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Antonella BARONE, University Magna Graecia of Catanzaro | ||||||||||||
Emerging strategies in gene delivery are increasingly turning to bioinspired platforms that mimic or repurpose natural carriers such as exosomes, extracellular vesicles, and hybrid nanostructures. This session explores how these biologically derived or biomimetic systems are redefining the landscape of genetic material transport, offering promising alternatives to conventional synthetic vectors. Leveraging the inherent advantages of natural carriers—such as biocompatibility, low immunogenicity, and innate targeting capabilities—bioinspired platforms enable more effective and precise delivery of nucleic acids, including mRNA, siRNA, and CRISPR components. Hybrid systems that combine biological and synthetic elements further expand the possibilities for customization and functionalization. The session will highlight recent advances in the engineering, functionalization, and translational application of these platforms, with a focus on their potential to address current limitations in gene therapy, vaccine development, and molecular medicine. | ||||||||||||
FE.II.6.1 TT.III.I.1 |
Introductive Keynote Alessia BROSSA University Magna Graecia of Catanzaro Extracellular Vesicle-Based Systems for Nucleic Acid Delivery: From Natural Carriers to Engineered Hybrids |
![]() |
||||||||||
FE.II.6.2 TT.III.I.2 |
in definition | ![]() |
||||||||||
FE.II.6.3 TT.III.I.3 |
in definition | ![]() |
||||||||||
FE.II.6.4 TT.III.I.4 |
in definition | ![]() |
||||||||||
FE.II.6.5 TT.III.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
16:00 - 17:30 The Key Role of Multi-Physics Simulations in the Energy Transition FE.II.7 - TT.IV.D - WS.I.4 |
||||||||||||
Co-organized with | ||||||||||||
![]() |
||||||||||||
Chair: Giulia MASSAGLIA, Polytechnic University of Turin | ||||||||||||
The increasing complexity of modern energy systems requires advanced tools to support their design, optimization, and real-time monitoring. Multiphysics simulations, which integrate various physical domains such as thermal, fluid dynamic, electrical, and structural behaviors, play a pivotal role in capturing the coupled phenomena that govern energy devices. These simulations form the foundation for the development of Digital Twins—virtual replicas of physical systems capable of mirroring their real-time state and predicting future behavior under different operational scenarios. By enabling high-fidelity modeling and dynamic updates through real-world data, Digital Twins can significantly enhance decision-making, predictive maintenance, and overall system efficiency. This work highlights the strategic role of multiphysics modeling in the development of reliable Digital Twins for energy applications, presenting key challenges and opportunities in this rapidly evolving field. | ||||||||||||
FE.II.7.1 TT.IV.D.1 WS.I.4.1 |
Introductive Keynote Nicolò VASILE Polytechnic University of Turin Title in definition |
![]() |
||||||||||
FE.II.7.2 TT.IV.D.2 WS.I.4.2 |
in definition | ![]() |
||||||||||
FE.II.7.3 TT.IV.D.3 WS.I.4.3 |
in definition | ![]() |
||||||||||
FE.II.7.4 TT.IV.D.4 WS.I.4.4 |
in definition | ![]() |
||||||||||
FE.II.7.5 TT.IV.D.5 WS.I.4.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
16:00 - 17:30 Polymeric Systems for RNA-Based Therapeutics FE.II.8 - TT.IV.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Delia MANDRACCHIA, University of Brescia | ||||||||||||
The evolution of RNA-based therapeutics—ranging from mRNA to siRNA and gene editing technologies—led to a critical demand for delivery systems that ensure stability, specificity and controlled release. This session focuses on polymeric platforms as versatile and tunable carriers for RNA molecules in therapeutic applications. Polymeric systems, including both natural and synthetic polymers, offer distinct advantages such as structural flexibility, chemical modifications and responsiveness to physiological stimuli. These features allow for engineering of delivery systems capable of overcoming biological barriers, enhancing cellular uptake and reducing off-target effects. Through discussion of recent advancements in polymer chemistry, nanostructure design and translational performance, the session will explore how these systems are being optimized to meet the complex requirements of RNA-based therapies. Special attention will be given to clinical potential, biodegradability, and scalability for future pharmaceutical development. | ||||||||||||
FE.II.8.1 TT.IV.I.1 |
Introductive Keynote Emanuela Fabiola CAPRARO University of Palermo Multicomponent Polymeric-based nanotools for siRNA inhalation |
![]() |
||||||||||
FE.II.8.2 TT.IV.I.2 |
in definition | ![]() |
||||||||||
FE.II.8.3 TT.IV.I.3 |
in definition | ![]() |
||||||||||
FE.II.8.4 TT.IV.I.4 |
in definition | ![]() |
||||||||||
FE.II.8.5 TT.IV.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
17:30 - 18:30 ROUND TABLE |
||||||||||||
Green Spritz - sorsi di sostenibilità | ||||||||||||
Keynote Speaker: Claudia Letizia BIANCHI, University of Milan | ||||||||||||
18 September | ||||||||||||
09:00 - 10:30 Advanced technologies for diagnostics, digitalization, and preservation of Cultural Heritage FE.II.9- TT.V.H |
||||||||||||
co-organized with Sapienza University of Rome | ||||||||||||
Chair: in definition | ||||||||||||
This session aims to highlight the promising role of advanced technologies for digitalization, research, conservation, and digital exhibition of Cultural Heritage. Emphasis will be placed on innovative applications such as high-resolution digital photogrammetry, 3D modeling, cutting-edge non-invasive techniques and AI. Special attention will be given to the emerging paradigm of Digital Twins, enabling dynamic, real-time replicas of heritage sites and artifacts that integrate IoT data, environmental monitoring, and predictive conservation models. The session also investigates how virtual reality (VR), augmented reality (AR), and live-guided digital platforms can transform remote access and inclusive engagement, particularly for inaccessible or fragile contexts, fostering new models of interactive learning, emotional engagement, and digital tourism. The session invites researchers and students in the fields of computer science and technology, museology, to contribute to interdisciplinary approaches that connect virtual archaeology, smart city systems, and digital humanities, aiming to redefine how cultural assets are understood, preserved, and shared in the 21 st century. | ||||||||||||
FE.II.9.1 TT.V.H.1 |
in definition | ![]() |
||||||||||
FE.II.9.2 TT.V.H.2 |
in definition | ![]() |
||||||||||
FE.II.9.3 TT.V.H.3 |
in definition | ![]() |
||||||||||
FE.II.9.4 TT.V.H.4 |
in definition | ![]() |
||||||||||
FE.II.9.5 TT.V.H.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
09:00 - 10:30 Smart nanomedicines and targeting properties FE.II.10 - TT.V.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Nicola D'AVANZO, University Magna Graecia of Catanzaro | ||||||||||||
Smart nanomedicines represent advanced nanoscale systems, particularly focusing on engineering methods. This session involves the design and functionalization of nanocarriers capable of active targeting, controlled release and real-time adaptation to complex physiological and pathological environments. A particular focus will be placed on targeting strategies—both passive and active—including ligand-receptor interactions and the use of disease-specific biomarkers to enhance selectivity. These features significantly improve therapeutic efficacy while minimizing systemic toxicity. The session will highlight recent developments in the integration of materials science, nanotechnology and molecular biology to realize next-generation nanomedicines. Emphasis will be placed on how these systems enable the rational design of precision therapeutics, supporting personalized interventions based on molecular disease signatures and patient-specific biological contexts. | ||||||||||||
FE.II.10.1 TT.V.I.1 |
Introductive Keynote Gabriella COSTABILE University of Naples "Federico II" Delivering RNA to the lung |
![]() |
||||||||||
FE.II.10.2 TT.V.I.2 |
in definition | ![]() |
||||||||||
FE.II.10.3 TT.V.I.3 |
in definition | ![]() |
||||||||||
FE.II.10.4 TT.V.I.4 |
in definition | ![]() |
||||||||||
FE.II.10.5 TT.V.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
11:30 - 13:00 Tomographic Techniques for Multiscale Imaging and Material Characterization FE.II.11 - TT.VI.H |
||||||||||||
Co-organized with Sapienza University of Rome | ||||||||||||
Chair: in definition | ||||||||||||
Tomographic techniques have become indispensable tools for non-destructive, high-resolution imaging across a wide range of scientific and engineering fields. This session will explore recent advances in tomographic methods, ranging from X-ray Computed Tomography and Electron Tomography to advanced Optical and Synchrotron-based approaches that enable multiscale visualization of structural, morphological, and functional properties in both biological and material systems. Particular emphasis will be placed on developments that push the boundaries of spatial resolution, contrast mechanisms, data reconstruction, and multimodal integration. Contributions addressing applications in materials science, life sciences and energy-related technologies are especially welcome. This session aims to foster cross-disciplinary dialogue and highlight how tomographic imaging is shaping our understanding of complex systems from the nanoscale to the macroscale. | ||||||||||||
FE.II.11.1 TT.VI.H.1 |
in definition | ![]() |
||||||||||
FE.II.11.2 TT.VI.H.2 |
in definition | ![]() |
||||||||||
FE.II.11.3 TT.VI.H.3 |
in definition | ![]() |
||||||||||
FE.II.11.4 TT.VI.H.4 |
in definition | ![]() |
||||||||||
FE.II.11.5 TT.VI.H.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
11:30 - 13:00 Bioadhesive Approaches for Drug Delivery FE.II.12 - TT.VI.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Maria Chiara CRISTIANO, University Magna Graecia of Catanzaro | ||||||||||||
This session explores the latest advances in the development of adhesive formulations capable of overcoming clearance mechanisms and enhancing drug retention at mucosal and epithelial sites. Topics will cover the design of muco- and cytoadhesive systems, the interplay between physicochemical properties and adhesive strength and the role of biological interface dynamics in influencing drug release profiles. Recent work on stimuli-responsive and environment-adaptive bioadhesive materials will also be presented, highlighting innovations that allow for controlled, site-specific delivery. By examining preclinical and translational data, the session aims to provide insight into how bioadhesion can be harnessed to address clinical challenges such as low bioavailability, rapid clearance and the need for non-invasive, patient-friendly delivery routes. | ||||||||||||
FE.II.12.1 TT.VI.I.1 |
Introductive Keynote Angela FABIANO University of Pisa Strategies for Evaluating Mucoadhesion in Chitosan-Based Pharmaceutical Systems |
![]() |
||||||||||
FE.II.12.2 TT.VI.I.2 |
in definition | ![]() |
||||||||||
FE.II.12.3 TT.VI.I.3 |
in definition | ![]() |
||||||||||
FE.II.12.4 TT.VI.I.4 |
in definition | ![]() |
||||||||||
FE.II.12.5 TT.VI.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
14:00 - 15:30 Impacts of nanomaterials and new advanced materials on health and safety in the workplace FE.II.13 - TT.VII.H |
||||||||||||
Co-organized with | ||||||||||||
![]() |
||||||||||||
Chair: Fabio BOCCUNI, INAIL | ||||||||||||
The manufacturing and use of nanomaterials and new advanced materials introduces emerging sources of emission of nanoscale particles in the work environments. The concerns are closely linked to the potential health effects of ultrafine particles for exposed workers, although the scientific evidence should be still improved to support this relationship. New safe and sustainable by-design approaches have been developed by application of the precautionary principle, to support enterprises in reducing the gap between the rapid growing of products marketplace and the risk management actions needed for the regulatory requirements. In parallel, opportunities provided by the application of the innovative properties of nanotechnologies may contribute to improve occupational health and safety levels, also in applications to the traditional risks. In this view materials with new and enhanced properties could be integrated in sensors and new technological devices to support the early detection of harmful substances in the work environment (i.e. chemical, carcinogenic and biological agents). The scope of the session is to explore new methodological approaches and innovative risk assessment and monitoring tools to guarantee healthy and safe workplace in the near future. |
||||||||||||
FE.II.13.1 TT.VII.H.1 |
Introductive Keynote Riccardo FERRANTE INAIL Title in definition |
![]() |
||||||||||
FE.II.13.2 TT.VII.H.2 |
in definition | ![]() |
||||||||||
FE.II.13.3 TT.VII.H.3 |
in definition | ![]() |
||||||||||
FE.II.13.4 TT.VII.H.4 |
in definition | ![]() |
||||||||||
FE.II.13.5 TT.VII.H.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
14:00 - 15:30 Responsive Drug Delivery Systems for skin therapies FE.II.14 - TT.VII.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Antonia MANCUSO, University Magna Graecia of Catanzaro | ||||||||||||
Responsive drug delivery systems are emerging as powerful tools for the treatment of skin diseases, offering the ability to adapt drug release in response to the local microenvironment. This session will explore innovative strategies designed to overcome the physiological barriers of the skin and improve therapeutic outcomes through localized, stimuli-sensitive delivery. Focus will be placed on the engineering of materials that react to pathological cues such as pH changes, inflammatory mediators, enzymatic activity, or oxidative stress—conditions commonly associated with chronic wounds, infections, and inflammatory skin disorders. These systems enable controlled drug activation and sustained therapeutic presence directly at the site of interest, reducing systemic exposure and improving efficacy. The session will present interdisciplinary approaches combining nanotechnology, polymer science, and cutaneous biology to develop next-generation platforms tailored for dermatological use, with an outlook toward personalized and targeted skin therapies. | ||||||||||||
FE.II.14.1 TT.VII.I.1 |
Introductive Keynote Cristina PARISI University of Catania Light-Controlled Nitric Oxide Release from Hyaluronic Acid Derivatives for Skin Delivery |
![]() |
||||||||||
FE.II.14.2 TT.VII.I.2 |
in definition | ![]() |
||||||||||
FE.II.14.3 TT.VII.I.3 |
in definition | ![]() |
||||||||||
FE.II.14.4 TT.VII.I.4 |
in definition | ![]() |
||||||||||
FE.I.14.5 TT.VII.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
16:00 - 17:30 From Reality to Representation: Digital Twins and their Role in Future Research FE.II.15 - TT.VIII.D - WS.I.8 |
||||||||||||
Co-organized with | ||||||||||||
![]() |
||||||||||||
Chair: Giulia MASSAGLIA, Polytechnic University of Turin | ||||||||||||
Digital Twins are emerging as a powerful paradigm to bridge the gap between the physical and digital worlds. Far beyond static models or offline simulations, Digital Twins are dynamic, continuously updated virtual counterparts of real systems - capable of supporting real-time monitoring, predictive analytics, and prescriptive decision-making. Their relevance spans from manufacturing to healthcare, from infrastructure management to biological systems. This symposium will open with a plenary lecture by Professor Andrea Matta from Politecnico di Milano, who will provide a comprehensive overview of the Digital Twin concept. Drawing from both historical foundations and recent research, Professor Matta will discuss key features, architectures, and classifications of Digital Twins - illustrating their transformative potential with practical examples from ongoing projects in the field of production systems and industrial automation. Following the plenary, the symposium will feature a series of short presentations by early-career researchers, highlighting innovative applications, methodological challenges, and interdisciplinary perspectives on the use of Digital Twins in various domains. The goal is to foster dialogue between established expertise and emerging ideas, and to explore how Digital Twins are shaping the future of research across disciplines. |
||||||||||||
FE.II.15.1 TT.VIII.D.1 WS.I.8.1 |
Introductive Keynote Andrea MATTA Polytechnic University of Milan Title in definition |
![]() |
||||||||||
FE.II.15.2 TT.VIII.D.2 WS.I.8.2 |
in definition | ![]() |
||||||||||
FE.II.15.3 TT.VIII.D.3 WS.I.8.3 |
in definition | ![]() |
||||||||||
FE.II.15.4 TT.VIII.D.4 WS.I.8.4 |
in definition | ![]() |
||||||||||
FE.II.15.5 TT.VIII.D.5 WS.I.8.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
16:00 - 17:30 Inorganic Nanocarriers for Therapy, Diagnosis and Imaging FE.II.16 - TT.VIII.I |
||||||||||||
co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: in definition | ||||||||||||
Inorganic nanocarriers represent a diverse class of engineered materials with highly tunable physicochemical properties, enabling their use across a wide range of biomedical applications. This session will explore the development and optimization of inorganic platforms—including gold nanoparticles, silica-based carriers, iron oxide nanostructures, and other metal- or mineral-based systems—designed for either therapeutic delivery, diagnostic sensing, or biomedical imaging. Discussion will focus on how material composition, morphology, and surface chemistry influence biological interactions, functional performance, and application-specific outcomes. Examples will include carriers tailored for targeted drug delivery, contrast enhancement in imaging modalities such as MRI or CT, and biosensing for molecular diagnostics. ather than emphasizing multifunctionality, the session highlights the multifunctionality of inorganic sistems, in the clinical workflow, offering modularity, scalability and features for personalized medicine and biomedical research. | ||||||||||||
FE.II.16.1 TT.VIII.I.1 |
Introductive Keynote Simone SPRIO CNR-ISSMC CaP nanoparticles for RNA delivery |
![]() |
||||||||||
FE.II.16.2 TT.VIII.I.2 |
in definition | ![]() |
||||||||||
FE.II.16.3 TT.VIII.I.3 |
in definition | ![]() |
||||||||||
FE.II.16.4 TT.VIII.I.4 |
in definition | ![]() |
||||||||||
FE.II.16.5 TT.VIII.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
19 September | ||||||||||||
09:00 - 10:30 Title in definition FE.II.17 - TT.IX.H |
||||||||||||
Co-organized with University of Milan | ||||||||||||
Chair: in definition | ||||||||||||
FE.II.17.1 TT.IX.H.1 |
Introductive Keynote Claudia Letizia Maddalena BIANCHI University of Milan Title in definition |
![]() |
||||||||||
FE.II.17.2 TT.IX.H.2 |
in definition | ![]() |
||||||||||
FE.II.17.3 TT.IX.H.3 |
in definition | ![]() |
||||||||||
FE.II.17.4 TT.IX.H.4 |
in definition | ![]() |
||||||||||
FE.II.17.5 TT.IX.H.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
09:00 - 10:30 Leveraging AI and Smart Technologies: Cross-Disciplinary Solutions in Healthcare and Disease Management FE.II.18 - TT.IX.I |
||||||||||||
Co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Andrea QUATTRONE, University Magna Graecia of Catanzaro | ||||||||||||
The integration of artificial intelligence (AI) and smart technologies is transforming the landscape of healthcare by enabling data-driven, adaptive, and predictive solutions. This session explores cross-disciplinary approaches that combine biomedical sciences, engineering, and computational methods to address current challenges in disease prevention, diagnosis, and management. Topics include the development of AI models for clinical decision support, real-time monitoring via wearable and implantable devices, and intelligent systems for personalized treatment planning. By converging fields such as machine learning, systems biology, and digital health, this session highlights how innovation can drive scalable, patient-centered strategies that advance both individual care and public health infrastructure. | ||||||||||||
FE.II.18.1 TT.IX.I.1 |
in definition | ![]() |
||||||||||
FE.II.18.2 TT.IX.I.2 |
in definition | ![]() |
||||||||||
FE.II.18.3 TT.IX.I.3 |
in definition | ![]() |
||||||||||
FE.II.18.4 TT.IX.I.4 |
in definition | ![]() |
||||||||||
FE.II.18.5 TT.IX.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
11:30 - 13:00 Multiscale Characterization of Materials: Bridging Structure and Function FE.II.19 - TT.X.H |
||||||||||||
co-organized with Sapienza University of Rome | ||||||||||||
Chair: in definition | ||||||||||||
Understanding the structural, chemical, and functional properties of materials across different length scales is essential for optimizing their performance and mechanisms. This session will highlight recent advances in multiscale characterization, integrating electron microscopy, spectroscopic techniques, surface and porosity analysis, X-ray-based methods and scanning probe microscopy (AFM and related techniques), enabling nanoscale resolution of electronic, mechanical, and chemical properties, as well as in situ and operando studies that capture material behaviour under real working conditions. The session will explore how a multi-technique approach allows for a deeper correlation between structure, morphology, and functional properties, providing key insights into the understanding of links between performances and properties. | ||||||||||||
FE.II.19.1 TT.X.H.1 |
in definition | ![]() |
||||||||||
FE.II.19.2 TT.X.H.2 |
in definition | ![]() |
||||||||||
FE.II.19.3 TT.X.H.3 |
in definition | ![]() |
||||||||||
FE.II.19.4 TT.X.H.4 |
in definition | ![]() |
||||||||||
FE.II.19.5 TT.X.H.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
11:30 - 13:00 AI-Powered Approaches in Neurodegenerative diseases FE.II.20 - TT.X.I |
||||||||||||
co-organized with University Magna Graecia of Catanzaro | ||||||||||||
Chair: Alessia BRAMANTI, University of Salerno | ||||||||||||
Artificial intelligence is rapidly becoming a key enabler in the study and clinical management of neurodegenerative diseases, where complexity and heterogeneity challenge conventional methodologies. This session focuses on AI-driven strategies for improving early detection, patient stratification, disease modeling and therapeutic development in conditions such as Alzheimer's, Parkinson's, ALS and related disorders. Topics will include the use of machine learning for multimodal data integration-encompassing imaging, genomics, proteomics, and clinical records-as well as the development of predictive models for disease onset, progression and treatment response. Key challenges such as model interpretability, cross-cohort performance, and applicability in clinical settings will also be discussed. By showcasing interdisciplinary efforts at the intersection of neuroscience, data science and clinical research, the session aims to provide a comprehensive overview of how AI technologies are reshaping our understanding and management of neurodegenerative conditions. | ||||||||||||
FE.II.20.1 TT.X.I.1 |
Introductive Keynote Andrea QUATTRONE University Magna Graecia of Catanzaro Artificial intelligence and imaging data in neurodegenerative diseases |
![]() |
||||||||||
FE.II.20.2 TT.X.I.2 |
in definition | ![]() |
||||||||||
FE.II.20.3 TT.X.I.3 |
in definition | ![]() |
||||||||||
FE.II.20.4 TT.X.I.4 |
in definition | ![]() |
||||||||||
FE.II.20.5 TT.X.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
14:00 - 15:30 Title in definition FE.II.21 - TT.XI.H |
||||||||||||
Co-organized with... to be defined | ||||||||||||
Chair: in definition | ||||||||||||
FE.II.21.1 TT.XI.H.1 |
in definition | ![]() |
||||||||||
FE.II.21.2 TT.XI.H.2 |
in definition | ![]() |
||||||||||
FE.II.21.3 TT.XI.H.3 |
in definition | ![]() |
||||||||||
FE.II.21.4 TT.XI.H.4 |
in definition | ![]() |
||||||||||
FE.II.21.5 TT.XI.H.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
16:00 - 17:30 Title in definition FE.II.22 - TT.XII.H |
||||||||||||
co-organized with ... to be defined Chair: in definition |
||||||||||||
FE.II.22.1 TT.XII.I.1 |
in definition | ![]() |
||||||||||
FE.II.22.2 TT.XII.I.2 |
in definition | ![]() |
||||||||||
FE.II.22.3 TT.XII.I.3 |
in definition | ![]() |
||||||||||
FE.II.22.4 TT.XII.I.4 |
in definition | ![]() |
||||||||||
FE.II.22.5 TT.XII.I.5 |
in definition | ![]() |
||||||||||
Round table on the Topic | ||||||||||||
17:30 - 20:00 Cocktail & Social |
||||||||||||